Bristol Myers Squibb Reports Third Quarter Financial Results for 2024

Merck Announces Third-Quarter 2024 Financial Results

Orthobond Appoints George Landau as EVP, Business Development and Commercialization

Northpond Ventures-Backed Transition Bio Raises $13.3M

Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical Programs

Pfizer Reports Strong Third-Quarter 2024 Results And Raises 2024 Guidance

BD Named Among the 100 Best Corporate Citizens of 2024

HR HealthCare Appoints Dallas Donald as VP and Melissa Georgeoff as Chief Contracting Officer

Avalon GloboCare Announces 1-for-15 Reverse Stock Split

Interview with Adam Low, CEO of SENTA Partners

Modifi Biosciences Acquired by Merck

Children’s Hospital of Philadelphia Leader Alexis A. Thompson Elected to National Academy of Medicine

AdaptHealth Appoints Diana Nole to Board of Directors

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer

AscellaHealth Acquires CHAPPER healthcare

US Digestive Health Appoints Seven New Physicians to Its Practice